Multiple myeloma (MM) is a B-cell malignancy characterized by the extensive proliferation of malignant plasma cells (PCs) in the bone marrow (BM) and an abnormal increase in monoclonal immunoglobulins or M proteins [1]. Here, MYOM2 is linked to Miyoshi myopathy.